Acute Lung Injury: Epidemiology, Pathogenesis, and Treatment

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Aerosol Medicine

• Publication date

  2010-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1089/jamp.2009.0775PMID 20073554PMCID PMC3133560
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fluid balance and the adult respiratory distress syndrome.

  2015cited by this paper
• Granulocytes mediate acute edematous lung injury in rabbits and in isolated rabbit lungs perfused with phorbol myristate acetate: role of oxygen radicals.

  2015cited by this paper
• Efficacy and Safety of Corticosteroids for Persistent Acute Respiratory Distress Syndrome

  2009cited by this paper
• Transepithelial migration of neutrophils: mechanisms and implications for acute lung injury.

  2009cited by this paper
• Recent trends in acute lung injury mortality: 1996–2005*

  2009cited by this paper
• Analytic Review: The Pathogenetic and Prognostic Value of Biologic Markers in Acute Lung Injury

  2009cited by this paper
• Racial and ethnic disparities in mortality from acute lung injury*

  2009cited by this paper
• Statin administration did not influence the progression of lung injury or associated organ failures in a cohort of patients with acute lung injury

  2009cited by this paper
• Randomized, Placebo-Controlled Trial of an Aerosolized Beta-2 Adrenergic Agonist (Albuterol) for the Treatment of Acute Lung Injury.

  2009cited by this paper
• Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury.

  2009cited by this paper
• Soluble intercellular adhesion molecule-1 and clinical outcomes in patients with acute lung injury

  2009cited by this paper
• A double-blind placebo-controlled study to evaluate the safety and efficacy of L-2-oxothiazolidine-4-carboxylic acid in the treatment of patients with acute respiratory distress syndrome*

  2008cited by this paper
• Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury

  2008cited by this paper
• Mortality rates for patients with acute lung injury/ARDS have decreased over time.

  2008cited by this paper
• Randomized clinical trial of activated protein C for the treatment of acute lung injury.

  2008cited by this paper
• Predictors of mortality in acute lung injury during the era of lung protective ventilation

  2008cited by this paper
• Biomarkers of inflammation, coagulation and fibrinolysis predict mortality in acute lung injury

  2008cited by this paper
• Preadmission use of statins and outcomes after hospitalization with pneumonia: population-based cohort study of 29,900 patients.

  2008cited by this paper
• Acute Lung Injury Edema Fluid Decreases Net Fluid Transport across Human Alveolar Epithelial Type II Cells*

  2007cited by this paper
• Prevention of endotoxin-induced systemic response by bone marrow-derived mesenchymal stem cells in mice.

  2007cited by this paper
• Intrapulmonary Delivery of Bone Marrow-Derived Mesenchymal Stem Cells Improves Survival and Attenuates Endotoxin-Induced Acute Lung Injury in Mice1

  2007cited by this paper
• Early elevation of plasma von Willebrand factor antigen in pediatric acute lung injury is associated with an increased risk of death and prolonged mechanical ventilation*

  2007cited by this paper
• Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury

  2007cited by this paper
• Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome.

  2006cited by this paper
• Pathogenetic and prognostic significance of altered coagulation and fibrinolysis in acute lung injury/acute respiratory distress syndrome*

  2006cited by this paper
• The β-agonist lung injury trial (BALTI) : A randomized placebo-controlled clinical trial

  2006cited by this paper
• Effects of early enteral feeding on the outcome of critically ill mechanically ventilated medical patients.

  2006cited by this paper
• The beta-agonist lung injury trial (BALTI): a randomized placebo-controlled clinical trial.

  2006cited by this paper
• From evidence to clinical practice: effective implementation of therapeutic hypothermia to improve patient outcome after cardiac arrest.

  2006cited by this paper
• Quality of life after acute respiratory distress syndrome: a meta-analysis

  2006cited by this paper
• Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury.

  2006cited by this paper
• Inhaled beta-2 agonist salbutamol and acute lung injury: an association with improvement in acute lung injury

  2006cited by this paper
• Statins and sepsis in patients with cardiovascular disease: a population-based cohort analysis.

  2006cited by this paper
• Comparison of two fluid-management strategies in acute lung injury.

  2006cited by this paper
• Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury.

  2006cited by this paper
• Incidence and outcomes of acute lung injury.

  2005influential reference
• Pediatric acute lung injury: prospective evaluation of risk factors associated with mortality.

  2005cited by this paper
• Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury*

  2005cited by this paper
• Apoptosis and epithelial injury in the lungs.

  2005cited by this paper
• Statin therapy is associated with fewer deaths in patients with bacteraemia

  2005cited by this paper
• Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management.

  2005cited by this paper
• Is there a role for beta-adrenoceptor agonists in the management of acute lung injury and the acute respiratory distress syndrome?

  2005cited by this paper
• Bone marrow-derived mesenchymal stem cells in repair of the injured lung.

  2005cited by this paper
• Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury

  2005cited by this paper
• Is There a Role for β-Adrenoceptor Agonists in the Management of Acute Lung Injury and the Acute Respiratory Distress Syndrome?

  2005cited by this paper
• Leukocyte elastase induces epithelial apoptosis: role of mitochondial permeability changes and Akt.

  2004cited by this paper
• Prior Statin Therapy Is Associated With a Decreased Rate of Severe Sepsis

  2004cited by this paper
• Comparison of Clinical Criteria for the Acute Respiratory Distress Syndrome with Autopsy Findings

  2004cited by this paper
• Significance of von Willebrand factor in septic and nonseptic patients with acute lung injury.

  2004cited by this paper
• Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects

  2003cited by this paper
• Effect of age on the development of ARDS in trauma patients.

  2003cited by this paper
• Incidence of acute lung injury in the United States.

  2003cited by this paper
• Early elevation of plasma soluble intercellular adhesion molecule-1 in pediatric acute lung injury identifies patients at increased risk of death and prolonged mechanical ventilation*

  2003cited by this paper
• Science review: Apoptosis in acute lung injury

  2003cited by this paper
• Plasma surfactant protein levels and clinical outcomes in patients with acute lung injury

  2003cited by this paper
• Early versus late enteral feeding of mechanically ventilated patients: results of a clinical trial.

  2002cited by this paper
• Kinetic and reversibility of mechanical ventilation-associated pulmonary and systemic inflammatory response in patients with acute lung injury

  2002cited by this paper
• High values of the pulmonary artery wedge pressure in patients with acute lung injury and acute respiratory distress syndrome

  2002cited by this paper
• Randomized, placebo-controlled trial of lisofylline for early treatment of acute lung injury and acute respiratory distress syndrome

  2002cited by this paper
• Lung epithelial fluid transport and the resolution of pulmonary edema.

  2002cited by this paper
• Fas/Fas Ligand System Mediates Epithelial Injury, but Not Pulmonary Host Defenses, in Response to Inhaled Bacteria

  2001cited by this paper
• A multi-centre, double-blind, placebo-controlled study of liposomal prostaglandin E1 (TLC C-53) in patients with acute respiratory distress syndrome

  2001cited by this paper
• Efficacy of low tidal volume ventilation in patients with different clinical risk factors for acute lung injury and the acute respiratory distress syndrome.

  2001cited by this paper
• Neutrophil-mediated epithelial injury during transmigration: role of elastase.

  2001cited by this paper
• Hypoxia reduces alveolar epithelial sodium and fluid transport in rats: reversal by beta-adrenergic agonist treatment.

  2001cited by this paper
• The effect of statins on mortality in patients with bacteremia.

  2001cited by this paper
• von Willebrand factor antigen is an independent marker of poor outcome in patients with early acute lung injury

  2001cited by this paper
• The acute respiratory distress syndrome.

  2000cited by this paper
• Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome.

  2000cited by this paper
• Ketoconazole for Early Treatment of Acute Lung Injury and Acute Respiratory Distress Syndrome

  2000cited by this paper
• Neutrophils as early immunologic effectors in hemorrhage- or endotoxemia-induced acute lung injury.

  2000cited by this paper
• Interobserver variation in interpreting chest radiographs for the diagnosis of acute respiratory distress syndrome.

  2000cited by this paper
• Ketoconazole for early treatment of acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. The ARDS Network.

  2000cited by this paper
• Interobserver variability in applying a radiographic definition for ARDS.

  1999cited by this paper
• Liposomal prostaglandin E1 (TLC C-53) in acute respiratory distress syndrome: a controlled, randomized, double-blind, multicenter clinical trial. TLC C-53 ARDS Study Group.

  1999cited by this paper
• Serial changes in surfactant-associated proteins in lung and serum before and after onset of ARDS.

  1999cited by this paper
• Continuous dose furosemide as a therapeutic approach to acute respiratory distress syndrome (ARDS).

  1999cited by this paper
• Gut mucosal atrophy after a short enteral fasting period in critically ill patients.

  1999cited by this paper
• Regulation of neutrophil activation in acute lung injury.

  1999cited by this paper
• The alveolar space is the site of intense inflammatory and profibrotic reactions in the early phase of acute respiratory distress syndrome.

  1999cited by this paper
• Epidemiology of acute lung injury and ARDS.

  1999cited by this paper
• Complement inhibition attenuates human lung transplant reperfusion injury: a multicenter trial.

  1999cited by this paper
• Continuous thermodilution cardiac output: clinical validation against a reference technique of known accuracy

  1999cited by this paper
• Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial.

  1999cited by this paper
• Posttranscriptional regulation of lung elastin expression involves binding of a developmentally regulated cytosolic protein to an open-reading frame cis-element in the messenger RNA.

  1999cited by this paper
• Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Inhaled Nitric Oxide in ARDS Study Group.

  1998cited by this paper
• Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase ntrial. Inhaled nitric oxide in ards study group

  1998cited by this paper
• Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial.

  1998cited by this paper
• Treatment with N-acetylcysteine during acute respiratory distress syndrome: a randomized, double-blind, placebo-controlled clinical study.

  1997cited by this paper
• Beta-adrenergic agonist stimulated alveolar fluid clearance in ex vivo human and rat lungs.

  1997cited by this paper
• Aerosolized Surfactant in Adults with Sepsis-Induced Acute Respiratory Distress Syndrome

  1996cited by this paper
• Parenteral versus enteral nutrition: morphological changes in human adult intestinal mucosa.

  1996cited by this paper
• Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. Exosurf Acute Respiratory Distress Syndrome Sepsis Study Group.

  1996cited by this paper
• Clinical risks for development of the acute respiratory distress syndrome.

  1995cited by this paper
• Clinical Investigations in Critical CareInflammatory Cytokines in the BAL of Patients With ARDS: Persistent Elevation Over Time Predicts Poor Outcome

  1995cited by this paper
• Parenteral nutrition is associated with intestinal morphologic and functional changes in humans.

  1995cited by this paper
• Improved survival of patients with acute respiratory distress syndrome (ARDS): 1983-1993.

  1995cited by this paper
• Report of the American-European Consensus conference on acute respiratory distress syndrome: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Consensus Committee.

  1994cited by this paper
• Early enteral feeding does not attenuate metabolic response after blunt trauma.

  1993cited by this paper
• Pathogenesis of fibrosis in acute lung injury.

  1992cited by this paper

• My approach to respiratory sepsis: pulmonary.

  2026cites this paper
• Short-Term Major Adverse Cardiovascular Events Following Postpartum Haemorrhage: A Cohort Study (The MACEPH Study).

  2026cites this paper
• Gut microbiota and metabolites in acute lung injury: mechanisms and therapeutic perspectives

  2026cites this paper
• Targeting the Keap1-Nrf2/GPX4 axis to suppress ferroptosis in acute lung injury.

  2026cites this paper
• Xuebijing injection ameliorates LPS-mediated acute lung injury via multi-target synergy by alleviating inflammation and ferroptosis

  2026cites this paper
• Cavin gene family and caveolae-related disorders: pathogenetic roles and possible mechanisms

  2026cites this paper
• Therapeutic potential of plant-derived tannic acid on pulmonary disorders in experimental models

  2026cites this paper
• 10-Hydroxy-2-decenoic acid ameliorates LPS-induced acute lung injury through targeting MD2-mediated inflammatory signaling pathways.

  2025cites this paper
• Phlda1 stabilized by Mettl14-mediated m6A modification promotes lipopolysaccharide-induced acute lung injury.

  2025cites this paper
• Liangxue Huoxue decoction protects against sepsis-induced acute lung injury by restoring gut microbiota and inhibiting inflammation and oxidative stress via the SIRT1/NF-κB/Nrf2 signaling pathway.

  2025cites this paper
• NOD1 promotes leukocyte clearance and limits inflammation in female mice during obesity‐associated acute lung injury

  2025cites this paper
• Viral infection and lipopolysaccharide: Pathological axis “lung–joints” as a potential cause of osteonecrosis

  2025cites this paper
• Peiminine as an Anti-Inflammatory Agent: Mechanisms and Therapeutic Applications Across Diseases

  2025cites this paper
• Histopathological Changes of Dexamethasone on Affected Lung of Rats

  2025cites this paper
• Editorial: Model organisms in respiratory pharmacology 2023

  2025cites this paper
• Nebulized liposomal drug delivery: a SWOT analysis in drug development.

  2025cites this paper
• Serum pharmacochemistry profiling combined with molecular docking analysis to reveal the pharmacodynamic material basis of Lonicerae japonicae flos against acute lung injury

  2025cites this paper
• Lung recruitment mechanics: coalescing tissue strains with organ expansion

  2025cites this paper
• Effects of remote ischemic preconditioning and/or erythropoietin on lung injury induced by skeletal ischemia reperfusion: role of the NLRP3 inflammasome

  2025cites this paper
• Lanreotide protects against LPS-induced inflammation in endothelial cells and mouse lungs

  2025cites this paper
• Astragaloside IV alleviates LPS-induced acute lung injury by regulating receptor C5aR1 and macrophage pyroptosis.

  2025cites this paper
• Phosphatidylserine-decorated delivery platform helps alleviate acute lung injury via potentiating macrophage targeting

  2025cites this paper
• Experimental Evidence of the Benefits of Acupuncture/Electroacupuncture for Acute Lung Injury/ Acute Respiratory Distress Syndrome: A Literature Review of Rodent Studies.

  2025cites this paper
• Claudin-17 Deficiency Drives Vascular Permeability and Inflammation Causing Lung Injury

  2025cites this paper
• The Pathophysiology of Acute Lung Injury following Intestinal Ischemia-Reperfusion.

  2025cites this paper
• Visualizing pulmonary pathologies using smart molecular fluorescent probes

  2025cites this paper
• The CXCL12/CXCR4 Axis in Sepsis-Induced Acute Lung Injury: Mechanisms and Therapeutic Potential

  2025cites this paper
• Hyaluronic acid-based microgels loaded with fluticasone furoate for bleomycin-induced acute lung injury treatment

  2025cites this paper
• YOD1 promotes ferroptosis in acute lung injury by deubiquitination of NCOA4

  2025cites this paper
• Golgi‐Targeted Viscosity Fluorescent Probe for Monitoring Acute Lung Injury

  2025cites this paper
• The Effect of Inhaled Ozone Therapy in Two-Hit Rat Model of Lipopolysaccharides-Induced Acute Lung Injury and Bleomycin-Induced Pulmonary Fibrosis

  2025cites this paper
• Fasudil alleviates lipopolysaccharides-triggered damage to BEAS-2B cells and human lung organoids by inducing CLDN4 expression.

  2025cites this paper
• Comprehensive bioinformatics analysis of ferroptosis-related genes and immune cell infiltration in LPS-induced acute lung injury.

  2025cites this paper
• Nicht-invasive respiratorische Unterstützung bei akuter respiratorischer Insuffizienz mit Fokus auf High-Flow-Sauerstofftherapie und nicht-invasive Beatmung

  2025cites this paper
• Polymethoxyflavones extracted from Bauhinia championii alleviate LPS-induced acute lung injury by ameliorating endoplasmic reticulum stress

  2025cites this paper
• The bidirectional interplay between gut dysbiosis and surgical complications: A systematic review.

  2025cites this paper
• Lifei Qingchang Tang attenuates acute lung injury via the NF-κB and MAPK signaling pathways

  2025cites this paper
• Targeted delivery of TGF-β mRNA to murine lung parenchyma using one-component ionizable amphiphilic Janus Dendrimers

  2025cites this paper
• Isoliensinine Prevents against Lipopolysaccharide induced Rat Acute Lung Injury and Sepsis via Inhibiting the Inflammatory Mediators

  2025cites this paper
• Rutin attenuates bleomycin-induced acute lung injury via miR-9-5p mediated NF-κB signaling inhibition: network pharmacology analysis and experimental evidence

  2025cites this paper
• Functionalized extracellular vesicles of mesenchymal stem cells for regenerative medicine

  2025cites this paper
• The impact of the inflammatory pulmonary microenvironment on the behavior and function of mesenchymal stromal cells

  2025cites this paper
• MICBG406A polymorphism reduces risk of mechanical ventilation and death during viral acute lung injury

  2025cites this paper
• Nebulized MSC exosomes promote the transdifferentiation of transitional state cells against acute lung injury through STAT3/Krt8/AQP5 axis.

  2025cites this paper
• Isofraxidin Attenuates Lipopolysaccharide-Induced Cytokine Release in Mice Lung and Liver Tissues via Inhibiting Inflammation and Oxidative Stress

  2025cites this paper
• NLRP3 promotes inflammatory signaling and IL-1β cleavage in acute lung injury caused by cell wall extract of Lactobacillus casei

  2025cites this paper
• Combating sepsis-induced acute lung injury: PARP1 inhibition mediates oxidative stress mitigation and miR-135a-5p/SMAD5/Nanog axis drives regeneration.

  2025cites this paper
• Special Issue “New Perspective in the Molecular Pathways Involved in Acute and Chronic Lung Injury”

  2025cites this paper
• Dimethyl fumarate improves sepsis-induced acute lung injury by inhibiting STING-mediated ferroptosis

  2025cites this paper
• Therapeutic role of gut microbiota in lung injury-related cognitive impairment

  2025cites this paper
• An exploration of the protective effects of Ginsenoside Rb1 against acute lung injury using network pharmacology, molecular docking, molecular dynamics simulations, and in vivo experiments.

  2025cites this paper
• Regulation of Inflammatory Lung Injury by Transforming Growth Factors.

  2025cites this paper
• Sevoflurane Attenuates Acute Lung Injury Following Intestinal Ischemia‐Reperfusion via Targeting NLRP3 Inflammasome

  2025cites this paper
• Octreotide and direct/indirect lung injury

  2025cites this paper
• Pedunculoside alleviates lipopolysaccharide-induced acute lung injury/acute respiratory distress syndrome by inhibiting NF-κB pathway

  2025cites this paper
• Engineering cells or cellular outer membranes as multifaceted vehicles for reinforcing nanomedicine-based pulmonary disease treatment

  2024cites this paper
• The multi-herbal decoction SH003 alleviates LPS-induced acute lung injury by targeting inflammasome and extracellular traps in neutrophils.

  2024cites this paper
• Targeted delivery of TGF-β mRNA to lung parenchyma using one-component ionizable amphiphilic Janus Dendrimers

  2024influential citation
• Synthetic Amphipathic Helical Peptide L-37pA Ameliorates the Development of Acute Respiratory Distress Syndrome (ARDS) and ARDS-Induced Pulmonary Fibrosis in Mice

  2024cites this paper
• Ameliorative effect of pedunculoside on sepsis-induced acute lung injury, inflammation and pulmonary fibrosis in mice model via suppressing AKT/NF-κB pathway

  2024cites this paper
• Analyzing small RNA sequences from canine stem cell-derived extracellular vesicles primed with TNF-α and IFN-γ and exploring their potential in lung repair

  2024cites this paper
• Bio-intelligent plasma-engineered diferuloylmethane/fucoidan/neutrophil lysate/iron oxide nanoclusters for phototherapeutic and magnetotherapeutic with in situ magnetic gelation mitigating inflammatory diseases.

  2024cites this paper
• Evaluation of the Therapeutic Potential of Sulfonyl Urea Derivatives as Soluble Epoxide Hydrolase (sEH) Inhibitors

  2024cites this paper
• Analysis of the Protective Effects of Rosa roxburghii-Fermented Juice on Lipopolysaccharide-Induced Acute Lung Injury in Mice through Network Pharmacology and Metabolomics

  2024cites this paper
• Unconventional activation of PRKDC by TNF-α: deciphering its crucial role in Th1-mediated inflammation beyond DNA repair as part of the DNA-PK complex

  2024cites this paper
• Mechanism of isorhynchophylline in lipopolysaccharide-induced acute lung injury based on proteomic technology

  2024cites this paper
• Imaging of the Spectrum of Acute Lung Injury.

  2024cites this paper
• Sea Cucumber and Blueberry Extracts Suppress Inflammation and Reduce Acute Lung Injury through the Regulation of NF-κB/MAPK/JNK Signaling Pathway in Lipopolysaccharide-Treated C57BL/6 Mice

  2024cites this paper
• Nrf2 activation: a key mechanism in stem cell exosomes-mediated therapies

  2024cites this paper
• Secretome profiling of human epithelial cells exposed to cigarette smoke extract and their effect on human lung microvascular endothelial cells

  2024cites this paper
• Breath of fresh air: Investigating the link between AGEs, sRAGE, and lung diseases.

  2024cites this paper
• The Interplay between Airway Cilia and Coronavirus Infection, Implications for Prevention and Control of Airway Viral Infections

  2024cites this paper
• Role of biomarkers and molecular signaling pathways in acute lung injury

  2024cites this paper
• A novel mechanism for regulating lung immune homeostasis: Zukamu granules alleviated acute lung injury in mice by inhibiting NLRP3 inflammasome activation and regulating Th17/Treg cytokine balance.

  2024cites this paper
• Alpinetin alleviates LPS-induced lung epithelial cell injury by inhibiting p38 and ERK1/2 signaling via aquaporin-1.

  2024cites this paper
• Circ_0114428 knockdown inhibits ROCK2 expression to assuage lipopolysaccharide-induced human pulmonary alveolar epithelial cell injury through miR-574-5p

  2024cites this paper
• Network Pharmacology Analysis of the Therapeutic Potential of Colchicine in Acute Lung Injury

  2024cites this paper
• Canine Stem Cell-derived Exosomes for Lung Inflammation: Efficacy of Intratracheal Versus Intravenous Administration in an Acute Lung Injury Mouse Model

  2024cites this paper
• LPS Increases Artery but Not Airway Contraction in Precision Cut Lung Slices from a Mouse Model of ARDS.

  2024cites this paper
• Increased Levels of hsa-miR-199a-3p and hsa-miR-382-5p in Maternal and Neonatal Blood Plasma in the Case of Placenta Accreta Spectrum

  2024cites this paper
• Hyperoside attenuates sepsis-induced acute lung injury by Nrf2 activation and ferroptosis inhibition.

  2024cites this paper
• Apium graveolens L. alleviates acute lung injury in human A-549 cells by reducing NF-κB and NLRP3 inflammasome signaling

  2024cites this paper
• Farnesoid X receptor (FXR) as a potential therapeutic target for lung diseases: a narrative review

  2024cites this paper
• Clinical trial to verify the safety of an automatic electric airway suction system: a multicenter prospective randomized study

  2024cites this paper
• Preclinical evaluation of a low cost mechanical ventilator

  2024cites this paper
• Harmonising cellular conversations: decoding the vital roles of extracellular vesicles in respiratory system intercellular communications

  2024cites this paper
• Mitoxantrone attenuates lipopolysaccharide-induced acute lung injury via inhibition of NEDD8 activating enzyme.

  2024cites this paper
• Exosomes as novel biomarkers in sepsis and sepsis related organ failure

  2024cites this paper
• OZONE THERAPY AMELIORATES LPS-INDUCED ACUTE LUNG INJURY IN MICE BY INHIBITING THE NLRP3/ASC/CASPASE-1 AXIS

  2024cites this paper
• Mitophagy and Ferroptosis in Sepsis-Induced ALI/ARDS: Molecular Mechanisms, Interactions and Therapeutic Prospects of Medicinal Plants

  2024cites this paper
• Impact of Curcumin on the IL-17A-Mediated p53-Fibrinolytic System: Mouse Proteomics and Integrated Human Fibrosis scRNAseq Insights

  2024cites this paper
• Baicalein suppresses inflammation and attenuates acute lung injury by inhibiting glycolysis via HIF‑1α signaling

  2024cites this paper
• Anti-Inflammatory Effects of Clematis terniflora Leaf on Lipopolysaccharide-Induced Acute Lung Injury

  2024cites this paper
• The Na/K-ATPase role as a signal transducer in lung inflammation

  2024cites this paper
• Total flavonoids of Selaginella tamariscina (P. Beauv.) Spring ameliorates diabetes-induced acute lung injury via activating Nrf2/HO-1

  2024cites this paper
• Nanoengineered Neutrophil as 19F‐MRI Tracer for Alert Diagnosis and Severity Assessment of Acute Lung Injury

  2024cites this paper
• Ameliorative Effect of Morinda Officinalis Oligosaccharides on LPS‐Induced Acute Lung Injury

  2024cites this paper
• Protective Activities of Growth Hormone-Releasing Hormone Antagonists against Toxin-Induced Endothelial Injury

  2024cites this paper
• Corilagin Inhibits Neutrophil Extracellular Trap Formation and Protects against Hydrochloric Acid/Lipopolysaccharide-Induced Acute Lung Injury in Mice by Suppressing the STAT3 and NOX2 Signaling Pathways

  2024cites this paper
• Sirt4 Overexpression Modulates the JAK2/STAT3 and PI3K/AKT/mTOR Axes to Alleviate Sepsis-Induced Acute Lung Injury

  2024cites this paper